Akorn has filed a complaint against Fresenius Kabi in Delaware Chancery Court after Fresenius moved to terminate its merger agreement with the company, according to an Akorn press release.
Fresenius announced the termination of the merger agreement Sunday, claiming Akorn has failed to fulfill several closing conditions and citing breaches of FDA data integrity requirements relating to Akorn’s operations, according to a press release from Fresenius.
Akorn, in turn, is asking the court that Fresenius be required to fulfill its obligations under the agreement.
“Fresenius’ attempt
Uncategorized